TH174353A - Non-nucleoside reverse transcriptase inhibitors (Non-Nucleoside reverse transcriptase inhibitors) - Google Patents
Non-nucleoside reverse transcriptase inhibitors (Non-Nucleoside reverse transcriptase inhibitors)Info
- Publication number
- TH174353A TH174353A TH1501001957A TH1501001957A TH174353A TH 174353 A TH174353 A TH 174353A TH 1501001957 A TH1501001957 A TH 1501001957A TH 1501001957 A TH1501001957 A TH 1501001957A TH 174353 A TH174353 A TH 174353A
- Authority
- TH
- Thailand
- Prior art keywords
- reverse transcriptase
- transcriptase inhibitors
- formula
- nucleoside reverse
- compounds
- Prior art date
Links
- 229940042402 Non-nucleoside reverse transcriptase inhibitors Drugs 0.000 title 2
- 239000002726 nonnucleoside reverse transcriptase inhibitor Substances 0.000 title 2
- 150000001875 compounds Chemical class 0.000 claims abstract 6
- 102000015084 HIV Reverse Transcriptase Human genes 0.000 claims abstract 4
- 108010078851 HIV Reverse Transcriptase Proteins 0.000 claims abstract 4
- 150000003839 salts Chemical class 0.000 claims abstract 4
- 239000011780 sodium chloride Substances 0.000 claims abstract 4
- 230000002265 prevention Effects 0.000 claims abstract 3
- 229960005030 OTHER VACCINES in ATC Drugs 0.000 claims abstract 2
- 102000004965 antibodies Human genes 0.000 claims abstract 2
- 108090001123 antibodies Proteins 0.000 claims abstract 2
- 239000003443 antiviral agent Substances 0.000 claims abstract 2
- 201000009910 diseases by infectious agent Diseases 0.000 claims abstract 2
- 239000003814 drug Substances 0.000 claims abstract 2
- 229940079593 drugs Drugs 0.000 claims abstract 2
- 239000004615 ingredient Substances 0.000 claims abstract 2
- 230000002401 inhibitory effect Effects 0.000 claims abstract 2
- 230000000977 initiatory Effects 0.000 claims abstract 2
- 230000000051 modifying Effects 0.000 claims abstract 2
- 239000003419 rna directed dna polymerase inhibitor Substances 0.000 claims abstract 2
- 238000002560 therapeutic procedure Methods 0.000 claims abstract 2
Abstract
สารประกอบตามสูตร I (สูตร) คือสารยับยั้ง HIV รีเวิร์ส ทรานสคริปเตส (HIV reverse transcriptase inhibitors), โดย ที่ R1, R2, R3, L, M และ Z คือที่ถูกนิยามไว้ในที่นี้ สารประกอบตามสูตร I และเกลือที่ยอมรับได้ ในทางเภสัชกรรมของพวกมัน จะมีประโยชน์ในการยับยั้ง HIV รีเวิร์สทรานสคริปเตส, การป้องกันและ การบำบัดการติดเชื้อโดย HIV และในการป้องกัน, การชะลอในการเริ่มต้น หรือการก้าวหน้า, และ การบำบัดของโรคเอดส์ (AIDS) สารประกอบและเกลือของพวกมันจะสามารถถูกใช้โดยเป็น ส่วนนผสมในองค์ประกอบเชิงเภสัชกรรม, อย่างเลือกได้ โดยร่วมกับสารต้านไวรัส, สารปรับควบคุม ภูมิคุ้มกัน, แอนติบอดี หรือวัคซีนอื่นๆ: สิทธิบัตรยา Compounds based on formula I (formula) are HIV reverse transcriptase inhibitors, where R1, R2, R3, L, M and Z are defined in the this Compounds according to formula I and acceptable salts In their pharmaceutical field It is useful in inhibiting HIV reverse transcriptase, preventing and Treatment of infection by HIV and in the prevention, delay in initiation. Or advancement, and AIDS therapy (AIDS) their compounds and salts can be used as Pharmaceutical ingredients, optional In combination with antiviral agents, immune modulators, antibodies or other vaccines: drug patent
Claims (1)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TH174353A true TH174353A (en) | 2018-03-15 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1124726T1 (en) | QUINAZOLINE DERIVATIVES USED TO TREAT HIV | |
| EA201890425A1 (en) | ANTI-VIRUS PHOSPHODIAMIDE COMPOSITE BETA-AMINO ACID COMPOUNDS | |
| MX2019007262A (en) | Antiviral benzyl-amine phosphodiamide compounds. | |
| EA201590674A1 (en) | DERIVATIVES OF 5-PHENOXY-3H-PYRIMIDIN-4-SHE AND THEIR APPLICATION AS HIV REVERSE TRANSCRIPASE INHIBITORS | |
| CY1118774T1 (en) | PHARMACEUTICAL COMPOSITION INCLUDING A NON-NUCLEOID REVERSE TRANSFER INFLUENCE | |
| EA201690687A1 (en) | REPLICATION INHIBITORS OF THE VIRUS OF IMMUNODEFICIENCY | |
| EA201791019A1 (en) | POLYCYCLIC CARBAMOILPYRIDONE COMPOUNDS AND THEIR PHARMACEUTICAL APPLICATIONS | |
| EA201590457A1 (en) | SULFAMOIL-Arylamides and Their Use as Medicinal Products for the Treatment of Hepatitis B | |
| EA201592200A1 (en) | DERIVATIVES OF SULFAMOILPYRROLAMIDE AND THEIR APPLICATION AS MEDICINES FOR THE TREATMENT OF HEPATITIS B | |
| BR112017013440A2 (en) | isoquinoline compounds for the treatment of hiv | |
| EA201590862A1 (en) | PHARMACEUTICAL COMPOSITIONS | |
| EA201591406A1 (en) | C-19 MODIFIED TRITERPENOIDS WITH INHIBITOR ACTIVITY OF HIV MATURATION | |
| CL2017000714A1 (en) | Long-acting pharmaceutical compositions | |
| CO2018001359A2 (en) | Derivatives of 5- (n-benzyl-tetrahydroisoquinolin-6-yl) -pyridin-3-yl acetic acid as inhibitors of human immunodeficiency virus replication | |
| EA201692270A1 (en) | DERIVATIVES OF NAFTYRIDINDIONE | |
| BR112018003181A2 (en) | compound, composition, and method for treating HIV infection | |
| EA201792122A1 (en) | CRYSTALLINE CONNECTION AS A STERICARBAS-SENSITIVE AMINOXIDASE ENZYME INHIBITOR (SSAO) | |
| TH174353A (en) | Non-nucleoside reverse transcriptase inhibitors (Non-Nucleoside reverse transcriptase inhibitors) | |
| BR112018000179A2 (en) | compound, composition, and method for treating HIV infection. | |
| TH180428A (en) | Senic Rivalok components and methods for their production and use. | |
| UA108495C2 (en) | Reverse transcriptase nucleoside inhibitors | |
| TH127245A (en) | Non-nucleoside reverse transcriptase inhibitors (NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS) | |
| UA114828C2 (en) | APPLICATION OF DECAMETOXIN AS A PHARMACEUTICAL ACTIVE SUBSTANCE FOR TREATMENT OF Gastrointestinal and Intestinal Infections Oral | |
| TH182826A (en) | Thyazine compounds and their use for medical purposes | |
| TH160505A (en) | Compounds and methods for enhancing the innate immune response |